Regulatory Updates
🇺🇸 FDA Page 23FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 265–276 of 373 articles
Top Biotech Stocks to Watch in May 2026: Clinical Trials Insights
FDA vs EMA: The Camizestrant Controversy
FDA Grants Early Access to Promising Drug for Pancreatic Cancer
FDA's New Form 483 Response Guidance: Implications for Pharma
BioMarin's SWOT Analysis: Competitive Challenges Ahead
FDA Drug Approval Decisions Expected in May 2026: What to Anticipate
Liminatus Pharma to Merge with InnocsAI: A Market Analysis
FDA Approves Expanded Access for Daraxonrasib in Pancreatic Cancer
FDA Approval for Datroway: Implications for Breast Cancer Treatment
Krystal Biotech Q1 Earnings Beat: Catalysts Ahead for 2026 & 2027
FDA Approves 17 Drugs with Continuous Manufacturing: Implications for Pharma
Palvella Secures $230M to Advance QTORIN for Rare Diseases